AB 1010 Mesylate
|
馬賽替尼
|
1048007-93-7
|
AZD1283
|
|
919351-41-0
|
Poricoic acid A(F)
|
茯苓酸A
|
137551-38-3
|
SU5201
|
|
114727-43-4
|
BETAZOLE HYDROCHLORIDE
|
鹽酸倍他唑
|
138-92-1
|
N-Cycloheptyl-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)acetamide hydrochloride
|
ICCB-19鹽酸鹽
|
1803605-68-6
|
Tussilagone
|
款冬酮
|
104012-37-5
|
exo-IWR 1
|
|
1127442-87-8
|
LDN212854
|
|
1432597-26-6
|
Dirithromycin
|
地紅霉素
|
62013-04-1
|
(R)-(+)-Corypalmine
|
D-四氫藥根堿
|
13063-54-2
|
1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one
|
普羅帕酮
|
54063-53-5
|
AT-101
|
|
866541-93-7
|
DUBs-IN-2
|
9-乙氧基亞氨基-9H-茚并[1,2-B]吡嗪-2,3-二甲腈
|
924296-19-5
|
Vonoprazan
|
沃諾拉贊
|
881681-00-1
|
Retro-2cycl
|
|
1429192-00-6
|
A -18
|
酪氨酸磷酸化抑制劑23
|
118409-57-7
|
(-)-MK-801 MALEATE
|
(+)-MK 801 順丁烯二酸鹽
|
77086-22-7
|
Inosine, compd. with 1-(dimethylamino)-2-propanol4-(acetylamino)benzoate (salt) (1:3)OTHER CA INDEX NAMES:2-Propanol, 1-(dimethylamino)-, 4-(acetylamino)benzoate (salt),compd. with inosine (3:1)Benzoic acid, 4-(acetylamino)-, compd. with1-(dimethylamino)-2-propanol and inosine (3:3:1)
|
異丙肌苷
|
36703-88-5
|
1-BCP
|
|
34023-62-6
|
RETAPAMULIN
|
瑞他莫林
|
224452-66-8
|
IRAK inhibitor 6
|
N-[2-甲氧基-4-(4-嗎啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰
|
1042672-97-8
|
Heteroclitin D(Standard Reference Material)
|
異型南五味子丁素
|
140369-76-2
|
IOX2
|
|
931398-72-0
|
Tar ocil
|
|
1200443-21-5
|
Radotinib
|
拉多替尼
|
926037-48-1
|
N-(Benzo[d]isoxazol-3-yl)-4-methylbenzamide
|
|
891025-25-5
|
AP-761
|
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸
|
1093108-50-9
|
5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole
|
|
2070014-93-4
|
(+)-5-(4-amino-3-methylphenyl)-7-(2-thiazolyl)-8,9-dihydro-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine
|
(R)-2-甲基-4-(8-甲基-7-(1,3,4-噻二唑-2-基)-8,9-二氫-7H-[1,3]二氧戊環(huán)并[4',5':4,5]苯并[1,2-D][1,2]二氮雜-5-基)苯胺
|
923272-18-8
|
Esculentoside A
|
商陸皂苷甲
|
65497-07-6
|
mavacoxib
|
嗎伐考昔
|
170569-88-7
|
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
|
6-[[3-[(二甲基氨基)羰基]苯基]磺酰]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉甲酰胺
|
801312-28-7
|
SC 66
|
|
871361-88-5
|
PF 04995274
|
|
1331782-27-4
|
H-ILE-TRP-OH
|
|
13589-06-5
|
4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid
|
化合物ZL006
|
1181226-02-7
|
B 45, HDAC3 Inhibitor
|
|
926259-99-6
|
4-Oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate
|
|
877636-42-5
|
R-Avanafil
|
4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2R)-2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲酰胺
|
1638497-26-3
|
"(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide "
|
2(4-環(huán)丙基苯基)-N[(1R)- 1 -[5 -(2,2,2-三氟乙氧基)吡啶-2-基]乙基]乙酰胺
|
953778-63-7
|
MX-69
|
|
1005264-47-0
|
(R)-(+)-8-methyl-5-(3-methyl-4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine
|
|
732277-05-3
|
DFHBI
|
|
1241390-29-3
|
(3bR-trans)-3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-phenanthro[1,2-c]furan-1(3H)-one
|
(3bR-反式)-3b,4,5,9b,10,11-六氫-6-羥基-9b-甲基-7-(1-甲基乙基)-菲并[1,2-c]呋喃-1(3H)-酮
|
74285-86-2
|
GSK620
|
|
2088410-46-0
|
SR1001
|
|
1335106-03-0
|
URB937
|
|
1357160-72-5
|
Telotristat
|
|
1033805-28-5
|
2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid
|
司替匹侖
|
866460-33-5
|
Neratinib maleate
|
馬來酸來那替尼
|
915942-22-2
|
DASa-58
|
3-[[4-[(2,3-二氫-1,4-苯并二惡英-6-基)磺?;鵠六氫-1H-1,4-二氮雜卓-1-基]磺酰基]苯胺
|
1203494-49-8
|
(R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE
|
|
732278-52-3
|
Shield-1
|
化合物SHIELD-1
|
914805-33-7
|
Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)-
|
|
2201056-66-6
|
Clinafloxacin
|
克林沙星
|
105956-97-6
|
Tetrahydroberberine
|
四氫小檗堿
|
522-97-4
|
RILPIVIRINE HCL
|
鹽酸利匹韋林
|
700361-47-3
|
DUBs-IN-3
|
9-[(2-丙烯-1-氧基)亞氨基]-9H-茚并[1,2-B]吡嗪-2,3-二甲腈
|
924296-17-3
|
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
|
雷芬那辛
|
864750-70-9
|
Basmisanil
|
巴米沙尼
|
1159600-41-5
|
Cyclic Somatostatin
|
合成生長抑素
|
38916-34-6
|
4-Acetamido-N-(2-amino-4-fluorophenyl)benzamide
|
|
1550053-02-5
|
PQ401
|
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-N渭-(2-methylquinolin-4-yl)urea
|
196868-63-0
|
Walrycin B
|
|
878419-78-4
|
2-(4-Isopropylpheny)-4H-chroMen-4-one
|
|
92831-11-3
|
5-(2-AMINO-4-OXO-3-(2-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUIZOLIN-6-YL)-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFOMIDE
|
|
1384097-27-1
|
KY 05009
|
|
1228280-29-2
|
Talniflumate
|
他尼氟酯Talniflumate
|
66898-62-2
|
Topiramate
|
托吡酯
|
97240-79-4
|
Picfeltarraenin IA
|
苦玄參苷IA
|
97230-47-2
|
SBE 13 hydrochloride
|
SBE13鹽酸鹽
|
1052532-15-6
|
A 804598
|
|
1125758-85-1
|
1175526-27-8
|
|
1175526-27-8
|
FGH-10019
|
|
1046045-61-7
|
YHO-13177
|
|
912287-56-0
|
DC-05
|
|
890643-16-0
|
YK 3-237
|
|
1215281-19-8
|
Cridanimod
|
|
1446418-48-9
|
LY 294002
|
LY-294,002鹽酸鹽
|
934389-88-5
|
Scopolamine butylbromide
|
N-丁基共聚溴化銨
|
149-64-4
|
EFONIDIPINE
|
依福地平
|
111011-63-3
|
SMER 28
|
|
307538-42-7
|
STF-118804
|
煙酰胺磷酸核糖基轉(zhuǎn)移酶
|
894187-61-2
|
ASP-9521
|
1-[1-[(5-甲氧基-1H-吲哚-2-基)羰基]哌啶-4-基]-2-甲基丙-2-醇
|
1126084-37-4
|
EFONIDIPINE
|
依福地平
|
111011-76-8
|
D-erythro-Hex-2-enonic acid, g-lactone, monosodium salt
|
異抗壞血酸鈉
|
6381-77-7
|
FASORACETAM
|
法索西坦
|
110958-19-5
|
S-Ruxolitinib (INCB018424)
|
S-魯索替尼
|
941685-37-6
|
PJ-34
|
PJ34 HCl 游離
|
344458-19-1
|
Norgestimate
|
炔諾肟酯
|
35189-28-7
|
BTYNB
|
2-(((5-溴噻吩-2-基)亞甲基)氨基)苯甲酰胺
|
304456-62-0
|
LDN-212320
|
|
894002-50-7
|
(8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate
|
|
1373431-65-2
|
(2R)-1,1,1-Trifluoro-2-[3-[(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl]sulfonylphenyl]propan-2-ol
|
|
946396-92-5
|
HSF1A
|
|
1196723-93-9
|
CDK-IN-2
|
|
1269815-17-9
|
UK-371804
|
化合物UK371804
|
256477-09-5
|
Ralinepag
|
|
1187856-49-0
|
sitravatinib
|
|
1123837-84-2
|